Principal Financial Group
SPPI

Principal Financial Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Principal Financial Group’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-48,301
Closed -$62K – 2691
2022
Q1 		$62K Sell
48,301
-1,089,859
-96% -$1M ﹤0.01% 2479
2021
Q4 		$1.45M Sell
1,138,160
-42,824
-4% -$76.6K ﹤0.01% 1921
2021
Q3 		$2.58M Buy
1,180,984
+5,812
+0.5% +$15.9K ﹤0.01% 1825
2021
Q2 		$4.41M Buy
1,175,172
+125,094
+12% +$435K ﹤0.01% 1748
2021
Q1 		$3.42M Buy
1,050,078
+16,155
+2% +$57.9K ﹤0.01% 1760
2020
Q4 		$3.53M Sell
1,033,923
-42,287
-4% -$174K ﹤0.01% 1669
2020
Q3 		$4.39M Buy
1,076,210
+181,515
+20% +$690K ﹤0.01% 1507
2020
Q2 		$3.02M Buy
894,695
+7,366
+0.8% +$21.5K ﹤0.01% 1601
2020
Q1 		$2.07M Sell
887,329
-35,787
-4% -$98K ﹤0.01% 1588
2019
Q4 		$3.36M Buy
923,116
+102
+0% +$824 ﹤0.01% 1634
2019
Q3 		$7.66M Buy
923,014
+39,411
+4% +$319K 0.01% 1348
2019
Q2 		$7.61M Buy
883,603
+6,167
+0.7% +$55.2K 0.01% 1367
2019
Q1 		$9.38M Buy
877,436
+24,142
+3% +$259K 0.01% 1267
2018
Q4 		$7.47M Buy
853,294
+21,080
+3% +$269K 0.01% 1323
2018
Q3 		$14M Buy
832,214
+73,210
+10% +$1.58M 0.01% 1099
2018
Q2 		$15.9M Buy
759,004
+37,667
+5% +$698K 0.01% 974
2018
Q1 		$11.6M Buy
721,337
+19,020
+3% +$377K 0.01% 1167
2017
Q4 		$13.3M Buy
702,317
+116,176
+20% +$2.1M 0.01% 1089
2017
Q3 		$8.25M Buy
586,141
+33,273
+6% +$301K 0.01% 1355
2017
Q2 		$4.12M Sell
552,868
-583
-0.1% -$3.81K ﹤0.01% 1611
2017
Q1 		$3.6M Buy
553,451
+24,245
+5% +$136K ﹤0.01% 1625
2016
Q4 		$2.34M Buy
529,206
+5,256
+1% +$22K ﹤0.01% 1693
2016
Q3 		$2.45M Buy
523,950
+83,970
+19% +$497K ﹤0.01% 1649
2016
Q2 		$2.89M Buy
439,980
+22,257
+5% +$157K ﹤0.01% 1583
2016
Q1 		$2.66M Buy
417,723
+16,178
+4% +$83K ﹤0.01% 1564
2015
Q4 		$2.42M Buy
401,545
+17,326
+5% +$99.1K ﹤0.01% 1588
2015
Q3 		$2.3M Buy
384,219
+7,336
+2% +$50.9K ﹤0.01% 1612
2015
Q2 		$2.58M Sell
376,883
-159
-0% -$1.01K ﹤0.01% 1635
2015
Q1 		$2.29M Buy
377,042
+9,928
+3% +$66.1K ﹤0.01% 1628
2014
Q4 		$2.54M Sell
367,114
-2,449
-0.7% -$18K ﹤0.01% 1632
2014
Q3 		$3.01M Buy
369,563
+12,652
+4% +$99K 0.01% 1554
2014
Q2 		$2.9M Buy
356,911
+7,534
+2% +$57.2K ﹤0.01% 1609
2014
Q1 		$2.74M Buy
349,377
+18,966
+6% +$161K ﹤0.01% 1592
2013
Q4 		$2.92M Buy
330,411
+23,015
+7% +$206K 0.01% 1588
2013
Q3 		$2.58M Buy
307,396
+14,215
+5% +$115K 0.01% 1582
2013
Q2 		$2.19M Buy
+293,181
New +$2.25M ﹤0.01% 1581

Other funds holding SPPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Principal Financial Group's SPPI Position: Q2 2022 in Review

Principal Financial Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2022, closing a stake of 48,301 shares — an estimated $62K sold.

Principal Financial Group first reported a position in SPPI in Q2 2013 and held it in 36 quarters. The position peaked at $15.9M in Q2 2018. 86 funds tracked by Wall St. Rank hold SPPI as of Q2 2022.

  • Principal Financial Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2022 after selling out during the quarter.
  • Principal Financial Group sold 48,301 Spectrum Pharmaceuticals Inc shares in Q2 2022, an estimated $62K.
  • Principal Financial Group first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 36 quarters.
  • Principal Financial Group's Spectrum Pharmaceuticals Inc position peaked at $15.9M in Q2 2018.
  • 86 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2022.

Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.